Advisors Management Group Inc Sorrento Therapeutics, Inc. Transaction History

Advisors Management Group Inc

  • $423 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 11, 2020
SELL
$1.57 - $4.76 $310,914 - $942,646
-198,035 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$2.67 - $4.38 $16 - $26
-6 Reduced -0.0%
198,035 $529,000
Q1 2019

May 13, 2019
BUY
$1.86 - $5.94 $368,356 - $1.18 Million
198,041 New
198,041 $941,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Advisors Management Group Inc Portfolio

Follow Advisors Management Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Management Group Inc , based on Form 13F filings with the SEC.

News

Stay updated on Advisors Management Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email